227 related articles for article (PubMed ID: 30217375)
21. Long-term safety and efficacy of Pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS]).
Suh SY; Rha SW; Ahn TH; Shin EK; Choi CU; Oh DJ; Bae JH; Hur SH; Yun KH; Oh SK; Kim JH; Kim SW; Chae IH; Kim KS; Hong YJ; Jeong MH;
Am J Cardiol; 2011 Dec; 108(11):1530-5. PubMed ID: 21890083
[TBL] [Abstract][Full Text] [Related]
22. Statin use increased new-onset diabetes in hypercholesterolemic individuals: Data from the Korean National Health Insurance Service-National Health Screening Cohort database (NHIS-HEALS).
Kim YS; Han YE; Choi EA; You NY; Lee JW; You HS; Kim Y; Kim J; Kang HT
Prim Care Diabetes; 2020 Jun; 14(3):246-253. PubMed ID: 31548127
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
24. The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.
Kim TM; Kim H; Jeong YJ; Baik SJ; Yang SJ; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1156-1163. PubMed ID: 28556206
[TBL] [Abstract][Full Text] [Related]
25. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
26. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
[TBL] [Abstract][Full Text] [Related]
27. Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database.
Lee J; Noh Y; Shin S; Lim HS; Park RW; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
Ther Clin Risk Manag; 2016; 12():1533-1543. PubMed ID: 27785041
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction: A propensity score matching analysis from the Korea Acute Myocardial Infarction Registry.
Won KB; Hur SH; Nam CW; Ann SH; Park GM; Lee SG; Kim HE; Cho YK; Yoon HJ; Park HS; Kim H; Han S; Jeong MH; Ahn YK; Rha SW; Kim CJ; Cho MC; Kim HS; Chae SC; Kim KS; Kim YJ; Kim KB; Barter P;
Medicine (Baltimore); 2017 Sep; 96(35):e7180. PubMed ID: 28858077
[TBL] [Abstract][Full Text] [Related]
29. Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries.
Bittner V; Colantonio LD; Dai Y; Woodward M; Mefford MT; Rosenson RS; Muntner P; Monda KL; Kilgore ML; Jaeger BC; Levitan EB
JAMA Cardiol; 2019 Sep; 4(9):865-872. PubMed ID: 31339519
[TBL] [Abstract][Full Text] [Related]
30. Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type.
Kim J; Kim HS; Yang W; Lee JW; Kang HT
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32872631
[TBL] [Abstract][Full Text] [Related]
31. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
Lee YJ; Hong SJ; Kang WC; Hong BK; Lee JY; Lee JB; Cho HJ; Yoon J; Lee SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
BMJ; 2023 Oct; 383():e075837. PubMed ID: 37852649
[TBL] [Abstract][Full Text] [Related]
33. Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease.
Zhang J; Wang J; Yu H; Wang G; Zhang J; Zhu R; Liu X; Li J
Curr Drug Metab; 2020; 21(10):818-828. PubMed ID: 32156233
[TBL] [Abstract][Full Text] [Related]
34. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
Tungsubutra W; Phongtuntakul B
J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
[TBL] [Abstract][Full Text] [Related]
35. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
36. [IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
Ovrakh T; Serik S; Kochubiei O
Georgian Med News; 2017 Apr; (265):7-14. PubMed ID: 28574378
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.
Yu JM; Chen WM; Shia BC; Wu SY
Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535
[TBL] [Abstract][Full Text] [Related]
38. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
[TBL] [Abstract][Full Text] [Related]
39. Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.
Colivicchi F; Gulizia MM; Franzini L; Imperoli G; Castello L; Aiello A; Ripellino C; Cataldo N
Adv Ther; 2016 Nov; 33(11):2049-2058. PubMed ID: 27671328
[TBL] [Abstract][Full Text] [Related]
40. Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction.
Kim MC; Cho JY; Jeong HC; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Seung KB; Chang K; Ahn Y
Am J Cardiol; 2015 Jan; 115(1):1-7. PubMed ID: 25456863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
